New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 28, 2022 - Celltrion USA announced the FDA approval of Vegzelma (bevacizumab-adcd), biosimilar to Genentech’s Avastin® (bevacizumab).
Download PDF
Return to publications
